UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial

Annals of oncology, 2014-09, Vol.25 (9), p.1762-1769

2014

Volltextzugriff (PDF)

Clinical Outcomes and Prognostic Features of Angiosarcoma: Significance of Prior Radiation Therapy

Clinical oncology (Royal College of Radiologists (Great Britain)), 2019-04, Vol.31 (4), p.232-241

2019

Volltextzugriff (PDF)

Improved clinical trial enrollments for uterine leiomyosarcoma patients after gynecologic oncology partnership with a sarcoma center

Gynecologic oncology, 2016-02, Vol.140 (2), p.307-312

2016

Volltextzugriff (PDF)

Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma

Annals of oncology, 2016-10, Vol.27 (10), p.1855-1860

2016

Volltextzugriff (PDF)

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

Annals of oncology, 2018-09, Vol.29 (9), p.1995-2002

2018

Volltextzugriff (PDF)

Multicenter, open-label phase II study of daily oral regorafenib for chemotherapy-refractory, metastatic and locally advanced angiosarcoma

Annals of oncology, 2018-10, Vol.29, p.viii592-viii592

2018

Volltextzugriff (PDF)

A phase II study of pazopanib with oral topotecan in patients with metastatic osteosarcoma

Annals of oncology, 2018-10, Vol.29, p.viii579-viii579

2018

Volltextzugriff (PDF)

Molecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950)

Annals of oncology, 2018-10, Vol.29, p.viii670-viii670

2018

Volltextzugriff (PDF)

A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults: Epithelioid sarcoma cohort (NCT02601950)

Annals of oncology, 2018-10, Vol.29, p.viii581-viii582

2018

Volltextzugriff (PDF)

19INMetabolic consequences of arginine deprivation in ASS1-deficient cancers

Annals of oncology, 2018-03, Vol.29 (suppl_3)

Van Tine, B

2018

Volltextzugriff (PDF)

Metabolic consequences of arginine deprivation in ASS1-deficient cancers

Annals of oncology, 2018-03, Vol.29, p.iii3-iii3

Van Tine, B.

2018

Volltextzugriff (PDF)

Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription

Genes & development, 2000-09, Vol.14 (18), p.2298-2313

2000

Volltextzugriff (PDF)

Assignment of N-acetyl-D-glucosaminidase (Mgea5) to rat chromosome 1q5 by tyramide fluorescence in situ hybridization (T-FISH): synteny between rat, mouse and human with Insulin Degradation Enzyme (IDE)

Cytogenetic and genome research, 2003-01, Vol.103 (1-2), p.202B-202B

2003

Volltextzugriff (PDF)

Human Papillomavirus DNA Replication Compartments in a Transient DNA Replication System

Journal of Virology, 1999-02, Vol.73 (2), p.1001-1009

1999

Volltextzugriff (PDF)

Combined xCT and mTOR Inhibition as a New Therapeutic Option for Pancreatic Adenocarcinoma

HPB (Oxford, England), 2022, Vol.24, p.S312-S313

2022

Volltextzugriff (PDF)

Functional Analysis of the Simian Immunodeficiency Virus Vpx Protein: Identification of Packaging Determinants and a Novel Nuclear Targeting Domain

Journal of Virology, 2001-01, Vol.75 (1), p.362-374

2001

Volltextzugriff (PDF)

Mother-to-Infant Transmission of the Human Immunodeficiency Virus during Primary Infection

The New England journal of medicine, 1999-11, Vol.341 (20), p.1548-1548

1999

Volltextzugriff (PDF)

1651PMulticenter, open-label phase II study of daily oral regorafenib for chemotherapy-refractory, metastatic and locally advanced angiosarcoma

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1019O Clinical and translational data from the phase I SURPASS trial of ADP-A2M4CD8 T cell receptor (TCR) T cell therapy alone or combined with nivolumab in solid tumors

Annals of oncology, 2023-10, Vol.34, p.S620-S621

2023

Volltextzugriff (PDF)

Characterization of CFTR expression and chloride channel activity in human endothelia

American Journal of Physiology: Cell Physiology, 1998-12, Vol.275 (6), p.C1555-C1564

1998

Volltextzugriff (PDF)

1610PDA phase II study of pazopanib with oral topotecan in patients with metastatic osteosarcoma

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

3:36 PM Abstract No. 256 Percutaneous tumor ablation in patients with metastatic sarcoma stable on chemotherapy

Journal of vascular and interventional radiology, 2018-04, Vol.29 (4), p.S110-S111

2018

Volltextzugriff (PDF)

Localization of HuC (ELAVL3) to chromosome 19p13.2 by fluorescence in situ hybridization utilizing a novel tyramide labeling technique

Genomics (San Diego, Calif.), 1998-11, Vol.53 (3), p.296-299

1998

Volltextzugriff (PDF)

1309TiPTrial in progress: First-in-human study of a novel anti-NY-ESO-1–anti-CD3, TCR-based bispecific (IMCnyeso) as monotherapy in NY-ESO-1/LAGE-1A-positive advanced solid tumours (IMCnyeso-101)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1309TiP - Trial in progress: First-in-human study of a novel anti-NY-ESO-1–anti-CD3, TCR-based bispecific (IMCnyeso) as monotherapy in NY-ESO-1/LAGE-1A-positive advanced solid tumours (IMCnyeso-101)

Annals of oncology, 2019-10, Vol.30, p.v532-v532

2019

Volltextzugriff (PDF)

1 – 25 von 221

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(209)
Mit Volltextzugriff
(199)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(221)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial

Clinical Outcomes and Prognostic Features of Angiosarcoma: Significance of Prior Radiation Therapy

Improved clinical trial enrollments for uterine leiomyosarcoma patients after gynecologic oncology partnership with a sarcoma center

Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

Multicenter, open-label phase II study of daily oral regorafenib for chemotherapy-refractory, metastatic and locally advanced angiosarcoma

A phase II study of pazopanib with oral topotecan in patients with metastatic osteosarcoma

Molecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950)

A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults: Epithelioid sarcoma cohort (NCT02601950)

19INMetabolic consequences of arginine deprivation in ASS1-deficient cancers

Metabolic consequences of arginine deprivation in ASS1-deficient cancers

Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription

Assignment of N-acetyl-D-glucosaminidase (Mgea5) to rat chromosome 1q5 by tyramide fluorescence in situ hybridization (T-FISH): synteny between rat, mouse and human with Insulin Degradation Enzyme (IDE)

Human Papillomavirus DNA Replication Compartments in a Transient DNA Replication System

Combined xCT and mTOR Inhibition as a New Therapeutic Option for Pancreatic Adenocarcinoma

Functional Analysis of the Simian Immunodeficiency Virus Vpx Protein: Identification of Packaging Determinants and a Novel Nuclear Targeting Domain

Mother-to-Infant Transmission of the Human Immunodeficiency Virus during Primary Infection

1651PMulticenter, open-label phase II study of daily oral regorafenib for chemotherapy-refractory, metastatic and locally advanced angiosarcoma

1019O Clinical and translational data from the phase I SURPASS trial of ADP-A2M4CD8 T cell receptor (TCR) T cell therapy alone or combined with nivolumab in solid tumors

Characterization of CFTR expression and chloride channel activity in human endothelia

1610PDA phase II study of pazopanib with oral topotecan in patients with metastatic osteosarcoma

3:36 PM Abstract No. 256 Percutaneous tumor ablation in patients with metastatic sarcoma stable on chemotherapy

Localization of HuC (ELAVL3) to chromosome 19p13.2 by fluorescence in situ hybridization utilizing a novel tyramide labeling technique

1309TiPTrial in progress: First-in-human study of a novel anti-NY-ESO-1–anti-CD3, TCR-based bispecific (IMCnyeso) as monotherapy in NY-ESO-1/LAGE-1A-positive advanced solid tumours (IMCnyeso-101)

1309TiP - Trial in progress: First-in-human study of a novel anti-NY-ESO-1–anti-CD3, TCR-based bispecific (IMCnyeso) as monotherapy in NY-ESO-1/LAGE-1A-positive advanced solid tumours (IMCnyeso-101)

Suchergebnisse filtern